Pharmaceutical Technology's Annual Employment Survey - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology's Annual Employment Survey
Nearly 1300 pharmaceutical employees provide insights into the issues most relevant to their jobs and the state of the industry workforce today.


Pharmaceutical Technology



Table I: Results overview: profile of a typical industry employee.
Their hours, ranks, and pay scales may vary, but pharmaceutical employees agree on many of the best and worst aspects of their jobs. Thanks to the nearly 1300 industry employees who participated in this year's survey, Pharmaceutical Technology highlights the issues directly affecting workers in the industry, including demographic information, education and work experience, salary and benefits, and attitudes toward current employment. Some overall results are summarized in Table I. When reviewing salary and benefits information, readers should take into account the range of experience, job functions, and educational certifications represented. No one statistic should be used for comparison without taking these factors into account.

Demographics


Figure 1. Percentage of male and female respondents.
Gender and age. Of the total number of responses, 67% overall came from men (see Figure 1). The average respondent age is 44 years. These values have remained relatively constant throughout the history of the survey.

Work location. Approximately 85% of the survey responses were received from industry workers in the United States, including Puerto Rico. Of these, approximately 14% work in New Jersey, 10% in Pennsylvania, and 9% in California; 6.5% each in New York, North Carolina, and Massachusetts; and 5.8% in Illinois. All other states each accounted for 3% or less of the total US responses. Other world regions represented less than 1% each of the total number of responses. Readers should take into account the number of responses received from each region when noting the results of this survey, especially salary results according to US region.


Figure 2. Highest level of education
Education and work experience. Fifty-four percent of employees have a degree beyond a bachelor's degree (see Figure 2). The most common fields of study were analytical chemistry (16%), biology or biology-related fields (12%), and pharmaceutics or pharmacy (12%). Nine percent of respondents earned degrees in engineering or engineering management. And 11% said they had studied in a field unrelated to pharmaceutical science or industry.

More than 72% of respondents said their experience prepared them very well for their current job functions, but only 34% said the same for their educations. Pharmaceutical employees reported an average of 19 years of professional work experience, including postdoctoral study.

Employment

Type of employer. As in previous Pharmaceutical Technology employment surveys, a preponderance of respondents (88%) indicated that they work in private industry, with 36% working at companies employing more than 10,000 people total. The percentage of respondents from academia or government was approximately 3% each. Therefore, the information provided in this article, including salary and attitudes toward current employment, best represents those working in the private sector.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here